Vasopressin and methylprednisolone for in-hospital cardiac arrest - Protocol for a randomized, double-blind, placebo-controlled trial

Lars W Andersen, Birthe Sindberg, Mathias Holmberg, Dan Isbye, Jesper Kjærgaard, Stine T Zwisler, Søren Darling, Jacob Moesgaard Larsen, Bodil S Rasmussen, Bo Løfgren, Kasper Glerup Lauridsen, Kim B Pælestik, Christoffer Sølling, Anders G Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette Gitz Charlot, Kasper Iversen, Martin Schultz, Sebastian Wiberg, Rikke Malene H G Jepsen, Tobias Kurth, Michael Donnino, Hans Kirkegaard, Asger Granfeldt, Lars W Andersen, Birthe Sindberg, Mathias Holmberg, Dan Isbye, Jesper Kjærgaard, Stine T Zwisler, Søren Darling, Jacob Moesgaard Larsen, Bodil S Rasmussen, Bo Løfgren, Kasper Glerup Lauridsen, Kim B Pælestik, Christoffer Sølling, Anders G Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette Gitz Charlot, Kasper Iversen, Martin Schultz, Sebastian Wiberg, Rikke Malene H G Jepsen, Tobias Kurth, Michael Donnino, Hans Kirkegaard, Asger Granfeldt

Abstract

Objective: To describe the clinical trial "Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest" (VAM-IHCA).

Methods: The VAM-IHCA trial is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of vasopressin and methylprednisolone during adult in-hospital cardiac arrest. The study drugs consist of 40 mg methylprednisolone and 20 IU of vasopressin given as soon as possible after the first dose of adrenaline. Additional doses of vasopressin (20 IU) will be administered after each adrenaline dose for a maximum of four doses (80 IU).The primary outcome is return of spontaneous circulation and key secondary outcomes include survival and survival with a favorable neurological outcome at 30 days. 492 patients will be enrolled. The trial was registered at the EU Clinical Trials Register (EudraCT Number: 2017-004773-13) on Jan. 25, 2018 and ClinicalTrials.gov (Identifier: NCT03640949) on Aug. 21, 2018.

Results: The trial started in October 2018 and the last patient is anticipated to be included in January 2021. The primary results will be reported after 3-months follow-up and are, therefore, anticipated in mid-2021.

Conclusion: The current article describes the design of the VAM-IHCA trial. The results from this trial will help clarify whether the combination of vasopressin and methylprednisolone when administered during in-hospital cardiac arrest improves outcomes.

Keywords: In-hospital cardiac arrest; Methylprednisolone; Randomized trial; Vasopressin.

© 2021 Published by Elsevier B.V.

Figures

Fig. 1
Fig. 1
Overview of the trial interventions.

References

    1. Holmberg M.J., Granfeldt A., Girotra S., Donnino M.W., Andersen L.W. Trends in survival and introduction of the 2010 and 2015 guidelines for adult in-hospital cardiac arrest. Resuscitation. 2020;157:112–120.
    1. Holmberg M.J., Ross C.E., Fitzmaurice G.M., Chan P.S., Duval-Arnould J., Grossestreuer A.V. Annual incidence of adult and pediatric in-hospital cardiac arrest in the United States. Circ Cardiovasc Qual Outcomes. 2019;12
    1. Andersen L.W., Holmberg M.J., Lofgren B., Kirkegaard H., Granfeldt A. Adult in-hospital cardiac arrest in Denmark. Resuscitation. 2019;140:31–36.
    1. Schluep M., Gravesteijn B.Y., Stolker R.J., Endeman H., Hoeks S.E. One-year survival after in-hospital cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2018;132:90–100.
    1. Andersen L.W., Holmberg M.J., Berg K.M., Donnino M.W., Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321:1200–1210.
    1. Callaway C.W., Soar J., Aibiki M., Bottiger B.W., Brooks S.C., Deakin C.D. Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2015;132:S84–145.
    1. Soar J., Nolan J.P., Bottiger B.W., Perkins G.D., Lott C., Carli P. European resuscitation council guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation. 2015;95:100–147.
    1. Link M.S., Berkow L.C., Kudenchuk P.J., Halperin H.R., Hess E.P., Moitra V.K. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association Guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S444–S464.
    1. Mentzelopoulos S.D., Zakynthinos S.G., Tzoufi M., Katsios N., Papastylianou A., Gkisioti S. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med. 2009;169:15–24.
    1. Mentzelopoulos S.D., Malachias S., Chamos C., Konstantopoulos D., Ntaidou T., Papastylianou A. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013;310:270–279.
    1. 2020. Website for the VAM-IHCA trial. Available from: .[cited 5 December 2020]
    1. ICH Harmonised Tripartite Guideline . 2016. Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2) Available from: . [cited 30 June 2017]
    1. ICH Harmonised Tripartite Guideline . 1997. General Considerations for Clinical Trials E8. Available from: . [cited 30 June 2017]
    1. ICH Harnomised Tripartite Guidelines . 1998. Statistical Principles for Clinical Trials. Available from: . [cited 30 June 2017]
    1. Chan A.W., Tetzlaff J.M., Altman D.G., Laupacis A., Gotzsche P.C., Krleza-Jeric K. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207.
    1. Chan A.W., Tetzlaff J.M., Gotzsche P.C., Altman D.G., Mann H., Berlin J.A. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
    1. Kernan W.N., Viscoli C.M., Makuch R.W., Brass L.M., Horwitz R.I. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19–26.
    1. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480–484.
    1. Haywood K. COSCA (core outcome set for cardiac arrest) in adults: an advisory statement from the international liaison committee on resuscitation. Resuscitation. 2018;127:147–163.
    1. Schulz K.F., Altman D.G., Moher D., Group C CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
    1. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
    1. Fergusson D., Aaron S.D., Guyatt G., Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ. 2002;325:652–654.
    1. Fernando S.M., Tran A., Cheng W., Rochwerg B., Taljaard M., Vaillancourt C. Pre-arrest and intra-arrest prognostic factors associated with survival after in-hospital cardiac arrest: systematic review and meta-analysis. BMJ. 2019;367:l6373.
    1. Hernandez A.V., Steyerberg E.W., Habbema J.D. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004;57:454–460.
    1. Kahan B.C., Jairath V., Dore C.J., Morris T.P. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials. 2014;15:139.
    1. Kahan B.C. Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how? BMC Med Res Methodol. 2014;14:20.
    1. Monsieurs K.G., Nolan J.P., Bossaert L.L., Greif R., Maconochie I.K., Nikolaou N.I. European resuscitation council guidelines for resuscitation 2015: section 1. Executive summary. Resuscitation. 2015;95:1–80.
    1. Danish Resuscitation Council Advanced Resusciation [Danish] Available from:
    1. Taichman D.B., Sahni P., Pinborg A., Peiperl L., Laine C., James A. Data sharing statements for clinical trials - a requirement of the international committee of medical journal editors. N Engl J Med. 2017;376:2277–2279.
    1. Lindner K.H., Haak T., Keller A., Bothner U., Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart. 1996;75:145–150.
    1. Miano T.A., Crouch M.A. Evolving role of vasopressin in the treatment of cardiac arrest. Pharmacotherapy. 2006;26:828–839.
    1. Paradis N.A., Martin G.B., Rivers E.P., Goetting M.G., Appleton T.J., Feingold M. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA. 1990;263:1106–1113.
    1. Wenzel V., Krismer A.C., Arntz H.R., Sitter H., Stadlbauer K.H., Lindner K.H. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350:105–113.
    1. Mentzelopoulos S.D., Zakynthinos S.G., Siempos I., Malachias S., Ulmer H., Wenzel V. Vasopressin for cardiac arrest: meta-analysis of randomized controlled trials. Resuscitation. 2012;83:32–39.
    1. Gueugniaud P.Y., David J.S., Chanzy E., Hubert H., Dubien P.Y., Mauriaucourt P. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med. 2008;359:21–30.
    1. Layek A., Maitra S., Pal S., Bhattacharjee S., Baidya D.K. Efficacy of vasopressin during cardio-pulmonary resuscitation in adult patients: a meta-analysis. Resuscitation. 2014;85:855–863.
    1. Stiell I.G., Hebert P.C., Wells G.A., Vandemheen K.L., Tang A.S., Higginson L.A. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358:105–109.
    1. Lindner K.H., Strohmenger H.U., Ensinger H., Hetzel W.D., Ahnefeld F.W., Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology. 1992;77:662–668.
    1. Smithline H., Rivers E., Appleton T., Nowak R. Corticosteroid supplementation during cardiac arrest in rats. Resuscitation. 1993;25:257–264.
    1. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21:55–89.
    1. Shi W.L., Zhang T., Zhou J.R., Huang Y.H., Jiang C.L. Rapid permissive action of dexamethasone on the regulation of blood pressure in a rat model of septic shock. Biomed Pharmacother. 2016;84:1119–1125.
    1. Varvarousi G., Stefaniotou A., Varvaroussis D., Xanthos T. Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovasc Drugs Ther. 2014;28:477–488.
    1. Botnaru T., Altherwi T., Dankoff J. Improved neurologic outcomes after cardiac arrest with combined administration of vasopressin, steroids, and epinephrine compared to epinephrine alone. CJEM. 2015;17:202–205.
    1. Ballew K.A. ACP Journal Club. Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest. Ann Intern Med. 2013;159:JC4.
    1. Buddineni J.P., Callaway C., Huang D.T. Epinephrine, vasopressin and steroids for in-hospital cardiac arrest: the right cocktail therapy? Crit Care. 2014;18:308.
    1. Hwang J.Y., Arredondo A.F., Paul T.K. Lung cancer screening, targeted temperature after cardiac arrest, and vasopressin and steroids in cardiac arrest. Am J Respir Crit Care Med. 2014;189:994–995.
    1. Donnino M.W., Andersen L.W., Berg K.M., Chase M., Sherwin R., Smithline H. Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial. Crit Care. 2016;20:82.
    1. Mentzelopoulos S.D., Slowther A.M., Fritz Z., Sandroni C., Xanthos T., Callaway C. Ethical challenges in resuscitation. Intensive Care Med. 2018;44:703–716.
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.
    1. The European Parliament and the Council of the European Unit . 2014. Clinical Trials Regulation (CTR) EU No 536/2014. Available from: . [cited 18 July 2017]
    1. van Belle G., Mentzelopoulos S.D., Aufderheide T., May S., Nichol G. International variation in policies and practices related to informed consent in acute cardiovascular research: results from a 44 country survey. Resuscitation. 2015;91:76–83.
    1. Mentzelopoulos D., Bossaert L., Raffay V., Askitopoulou H., Perkins G.D., Greif R. A survey of key opinion leaders on ethical resuscitation practices in 31 European Countries. Resuscitation. 2016;100:11–17.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다